The Trump administration is reviving the long-dormant Alien Terrorist Removal Court. But it isn’t the first court the U.S. has recalled to life to try an accused terrorist. Aaron Zelinsky on what a forgotten U.S. court in 1978 West Berlin can teach us.
www.lawfaremedia.org/article/back...
www.lawfaremedia.org/article/back...
Back to the Future: The U.S. Court for Berlin’s Lessons for the ATRC
A half-century ago, the United States brought to life a moribund court in West Berlin; that experience provides lessons for today’s ATRC
www.lawfaremedia.org
November 10, 2026 at 12:34 AM
The Trump administration is reviving the long-dormant Alien Terrorist Removal Court. But it isn’t the first court the U.S. has recalled to life to try an accused terrorist. Aaron Zelinsky on what a forgotten U.S. court in 1978 West Berlin can teach us.
www.lawfaremedia.org/article/back...
www.lawfaremedia.org/article/back...
#$ATRC: Dark pool prints by session, % of volume in brackets: Nov 13 193,839 (34.7%).
Nov 13: dark pool volume 0.6x normal, trending fading across 5 sessions.
Full story at the link.
#darkpool #stocks #stockmarket
Nov 13: dark pool volume 0.6x normal, trending fading across 5 sessions.
Full story at the link.
#darkpool #stocks #stockmarket
AtriCure (ATRC) Technical Levels: Options Flow, Dark Pools Line Up Below $57.48
ATRC at $56.84: support $54.74, resistance $57.48; the chart, options flow and dark pools line up bearish.
globaltradersacademy.com
November 14, 2026 at 1:07 AM
#$ATRC: Dark pool prints by session, % of volume in brackets: Nov 13 193,839 (34.7%).
Nov 13: dark pool volume 0.6x normal, trending fading across 5 sessions.
Full story at the link.
#darkpool #stocks #stockmarket
Nov 13: dark pool volume 0.6x normal, trending fading across 5 sessions.
Full story at the link.
#darkpool #stocks #stockmarket
🚨 $ATRC
JOHNSON B KRISTINE (Insider) sold 2,452 shares at an average price of $58.4800 per common share. (Date: 2026-11-06)
JOHNSON B KRISTINE (Insider) sold 2,452 shares at an average price of $58.4800 per common share. (Date: 2026-11-06)
SEC Filing: ATRC
Click to view the official SEC document.
www.sec.gov
November 10, 2026 at 9:04 PM
🚨 $ATRC
JOHNSON B KRISTINE (Insider) sold 2,452 shares at an average price of $58.4800 per common share. (Date: 2026-11-06)
JOHNSON B KRISTINE (Insider) sold 2,452 shares at an average price of $58.4800 per common share. (Date: 2026-11-06)
AtriCure (#$ATRC) Technical Levels: Options Flow Mixed Between $56.99 and $59.42.
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Read the full article for the full details.
#optionsflow #stocks #optionstrading #fintwit
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Read the full article for the full details.
#optionsflow #stocks #optionstrading #fintwit
AtriCure (ATRC) Technical Levels: Options Flow Mixed Between $56.99 and $59.42
ATRC at $57.78: support $56.99, resistance $59.42; the chart, options flow and dark pools are mixed.
globaltradersacademy.com
November 10, 2026 at 3:03 AM
AtriCure (#$ATRC) Technical Levels: Options Flow Mixed Between $56.99 and $59.42.
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Read the full article for the full details.
#optionsflow #stocks #optionstrading #fintwit
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Read the full article for the full details.
#optionsflow #stocks #optionstrading #fintwit
Hamdan Foundation partners with Advanced Technology Research Council to develop talent assessment tools.
🔗 Read the full story on GazeWire
#AI #UAE #ResearchAndDevelopment #GazeWire
🔗 Read the full story on GazeWire
#AI #UAE #ResearchAndDevelopment #GazeWire
Hamdan Foundation partners with Advanced Technology Research Council to develop talent assessment tools.
Hamdan Foundation and ATRC Partner for Talent Development
gazewire.com
November 14, 2026 at 10:59 AM
Hamdan Foundation partners with Advanced Technology Research Council to develop talent assessment tools.
🔗 Read the full story on GazeWire
#AI #UAE #ResearchAndDevelopment #GazeWire
🔗 Read the full story on GazeWire
#AI #UAE #ResearchAndDevelopment #GazeWire
#$ATRC · AtriCure releases three-year CEASE-AF study results
On November 11, 2026, AtriCure released results from its three-year CEASE-AF study. The data confirm the long-term effectiveness of hybrid ablation compared to catheter ablation alone.
#stocks #investing
On November 11, 2026, AtriCure released results from its three-year CEASE-AF study. The data confirm the long-term effectiveness of hybrid ablation compared to catheter ablation alone.
#stocks #investing
AtriCure releases three-year CEASE-AF study results
On November 11, 2026, AtriCure released results from its three-year CEASE-AF study. The data confirm the long-term effectiveness of hybrid ablation compared to catheter ablation alone.
insiderpost.org
November 13, 2026 at 6:26 AM
#$ATRC · AtriCure releases three-year CEASE-AF study results
On November 11, 2026, AtriCure released results from its three-year CEASE-AF study. The data confirm the long-term effectiveness of hybrid ablation compared to catheter ablation alone.
#stocks #investing
On November 11, 2026, AtriCure released results from its three-year CEASE-AF study. The data confirm the long-term effectiveness of hybrid ablation compared to catheter ablation alone.
#stocks #investing
🚨 $ATRC
B KRISTINE JOHNSON DECLARATION TRUST, a Director, filed a notice of intent to sell 2,452 shares of common stock, valued at approximately $143,397.13, on 11/06/2026.
B KRISTINE JOHNSON DECLARATION TRUST, a Director, filed a notice of intent to sell 2,452 shares of common stock, valued at approximately $143,397.13, on 11/06/2026.
SEC Filing: ATRC
Click to view the official SEC document.
www.sec.gov
November 6, 2026 at 9:05 PM
🚨 $ATRC
B KRISTINE JOHNSON DECLARATION TRUST, a Director, filed a notice of intent to sell 2,452 shares of common stock, valued at approximately $143,397.13, on 11/06/2026.
B KRISTINE JOHNSON DECLARATION TRUST, a Director, filed a notice of intent to sell 2,452 shares of common stock, valued at approximately $143,397.13, on 11/06/2026.
🔴 #ATRC — Privitera Salvatore, Chief Technical Officer
SOLD: 8,404 shares @ $65.00
Total: $546K
Filed Nov 3, 2026 · 7:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/ATRC
#InsiderTrading #ATRC #StockMarket
SOLD: 8,404 shares @ $65.00
Total: $546K
Filed Nov 3, 2026 · 7:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/ATRC
#InsiderTrading #ATRC #StockMarket
FormDelta — Insider Trading Alerts
Privitera Salvatore just sold $546K in ATRC. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
November 5, 2026 at 9:28 PM
🔴 #ATRC — Privitera Salvatore, Chief Technical Officer
SOLD: 8,404 shares @ $65.00
Total: $546K
Filed Nov 3, 2026 · 7:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/ATRC
#InsiderTrading #ATRC #StockMarket
SOLD: 8,404 shares @ $65.00
Total: $546K
Filed Nov 3, 2026 · 7:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/ATRC
#InsiderTrading #ATRC #StockMarket
🚨 $ATRC
Privitera Salvatore (Chief Technical Officer) sold 8,404 shares at an average price of $65.0000 per common share. (Date: 2026-11-04)
Privitera Salvatore (Chief Technical Officer) sold 8,404 shares at an average price of $65.0000 per common share. (Date: 2026-11-04)
SEC Filing: ATRC
Click to view the official SEC document.
www.sec.gov
November 5, 2026 at 9:38 PM
🚨 $ATRC
Privitera Salvatore (Chief Technical Officer) sold 8,404 shares at an average price of $65.0000 per common share. (Date: 2026-11-04)
Privitera Salvatore (Chief Technical Officer) sold 8,404 shares at an average price of $65.0000 per common share. (Date: 2026-11-04)
#$ATRC · AtriCure reports quarterly results and updates product line
AtriCure announced the availability of its third-quarter report on November 3, 2026. This allows shareholders to review progress in medical solution development.
#stocks #investing
AtriCure announced the availability of its third-quarter report on November 3, 2026. This allows shareholders to review progress in medical solution development.
#stocks #investing
AtriCure reports quarterly results and updates product line
AtriCure announced the availability of its third-quarter report on November 3, 2026. This allows shareholders to review progress in medical solution development.
insiderpost.org
November 7, 2026 at 6:11 AM
#$ATRC · AtriCure reports quarterly results and updates product line
AtriCure announced the availability of its third-quarter report on November 3, 2026. This allows shareholders to review progress in medical solution development.
#stocks #investing
AtriCure announced the availability of its third-quarter report on November 3, 2026. This allows shareholders to review progress in medical solution development.
#stocks #investing
Last month, in a draft decision, the ATRC supported claims against China by Platinum Equity-owned building products manufacturer Ventora and the Australian Glass and Window Association (AGWA).
Platinum Equity eh?
Shareholder/investor driven, not Australian workers driven then ?
Platinum Equity eh?
Shareholder/investor driven, not Australian workers driven then ?
November 6, 2026 at 11:30 PM
Last month, in a draft decision, the ATRC supported claims against China by Platinum Equity-owned building products manufacturer Ventora and the Australian Glass and Window Association (AGWA).
Platinum Equity eh?
Shareholder/investor driven, not Australian workers driven then ?
Platinum Equity eh?
Shareholder/investor driven, not Australian workers driven then ?
🔍 Nov 5, 2026: 📌 MONITOR signals today
📌 MONITOR tier (watch only): #EXEL #DOCU #OSPN #ATRC #CDNA
Full report → https://jumpstartsignal.com/reports/2026/11/05/
Free email: ✅ OPPORTUNITY & 🏆 SPOTLIGHT every trading day → https://jumpstartsignal.com
#technicalanalysis #stocks #fintwit
📌 MONITOR tier (watch only): #EXEL #DOCU #OSPN #ATRC #CDNA
Full report → https://jumpstartsignal.com/reports/2026/11/05/
Free email: ✅ OPPORTUNITY & 🏆 SPOTLIGHT every trading day → https://jumpstartsignal.com
#technicalanalysis #stocks #fintwit
Jumpstart Signal - November 5, 2026
SRI-filtered stock screening report for November 5, 2026. Daily signals with technical analysis and sentiment.
jumpstartsignal.com
November 6, 2026 at 1:44 PM
🔍 Nov 5, 2026: 📌 MONITOR signals today
📌 MONITOR tier (watch only): #EXEL #DOCU #OSPN #ATRC #CDNA
Full report → https://jumpstartsignal.com/reports/2026/11/05/
Free email: ✅ OPPORTUNITY & 🏆 SPOTLIGHT every trading day → https://jumpstartsignal.com
#technicalanalysis #stocks #fintwit
📌 MONITOR tier (watch only): #EXEL #DOCU #OSPN #ATRC #CDNA
Full report → https://jumpstartsignal.com/reports/2026/11/05/
Free email: ✅ OPPORTUNITY & 🏆 SPOTLIGHT every trading day → https://jumpstartsignal.com
#technicalanalysis #stocks #fintwit
🚨 $ATRC
SALVATORE PRIVITERA, a Officer, filed a notice of intent to sell 8,404 shares of common stock, valued at approximately $546,260.00, on 11/04/2026.
SALVATORE PRIVITERA, a Officer, filed a notice of intent to sell 8,404 shares of common stock, valued at approximately $546,260.00, on 11/04/2026.
SEC Filing: ATRC
Click to view the official SEC document.
www.sec.gov
November 4, 2026 at 9:09 PM
🚨 $ATRC
SALVATORE PRIVITERA, a Officer, filed a notice of intent to sell 8,404 shares of common stock, valued at approximately $546,260.00, on 11/04/2026.
SALVATORE PRIVITERA, a Officer, filed a notice of intent to sell 8,404 shares of common stock, valued at approximately $546,260.00, on 11/04/2026.
#$ATRC · AtriCure reports third-quarter 2026 earnings
AtriCure reported $154,450,000 in revenue for the third quarter of 2026, a 15% increase year-over-year. Net income for the quarter was $4,064,000, compared to a $267,000 loss in the third quarter of 2025.
#stocks #investing
AtriCure reported $154,450,000 in revenue for the third quarter of 2026, a 15% increase year-over-year. Net income for the quarter was $4,064,000, compared to a $267,000 loss in the third quarter of 2025.
#stocks #investing
AtriCure reports third-quarter 2026 earnings
AtriCure reported $154,450,000 in revenue for the third quarter of 2026, a 15% increase year-over-year. Net income for the quarter was $4,064,000, compared to a $267,000 loss in the third quarter of 2025.
insiderpost.org
November 6, 2026 at 6:41 AM
#$ATRC · AtriCure reports third-quarter 2026 earnings
AtriCure reported $154,450,000 in revenue for the third quarter of 2026, a 15% increase year-over-year. Net income for the quarter was $4,064,000, compared to a $267,000 loss in the third quarter of 2025.
#stocks #investing
AtriCure reported $154,450,000 in revenue for the third quarter of 2026, a 15% increase year-over-year. Net income for the quarter was $4,064,000, compared to a $267,000 loss in the third quarter of 2025.
#stocks #investing
#$ATRC · AtriCure reports third-quarter progress
On November 3, 2026, AtriCure, Inc. released its third-quarter earnings report. The document highlighted progress in supporting physicians, advancing innovation, and assisting patients globally.
#stocks #investing
On November 3, 2026, AtriCure, Inc. released its third-quarter earnings report. The document highlighted progress in supporting physicians, advancing innovation, and assisting patients globally.
#stocks #investing
AtriCure reports third-quarter progress
On November 3, 2026, AtriCure, Inc. released its third-quarter earnings report. The document highlighted progress in supporting physicians, advancing innovation, and assisting patients globally.
insiderpost.org
November 5, 2026 at 6:26 AM
#$ATRC · AtriCure reports third-quarter progress
On November 3, 2026, AtriCure, Inc. released its third-quarter earnings report. The document highlighted progress in supporting physicians, advancing innovation, and assisting patients globally.
#stocks #investing
On November 3, 2026, AtriCure, Inc. released its third-quarter earnings report. The document highlighted progress in supporting physicians, advancing innovation, and assisting patients globally.
#stocks #investing
$PPLI (+9.06%), $ECHO (-3.26%), $CPNG (+11.95%), $UWMC (+6.29%), and $ATRC (+8.48%) just dropped some of the wildest earnings surprises of the season. $PPLI soared on a massive miss, while $ECHO slid on a giant beat. The engine prefers $ATRC's quality (Dad Score 90.9) over $CPNG's expensive growth.
November 5, 2026 at 1:21 AM
$PPLI (+9.06%), $ECHO (-3.26%), $CPNG (+11.95%), $UWMC (+6.29%), and $ATRC (+8.48%) just dropped some of the wildest earnings surprises of the season. $PPLI soared on a massive miss, while $ECHO slid on a giant beat. The engine prefers $ATRC's quality (Dad Score 90.9) over $CPNG's expensive growth.
📄 #ATRC 10-Q — what changed
MD&A now says: "This discussion and analysis are intended to provide an understanding of our results of operations, financial condition and cash flows and contain forward-looking statements reflecting current expectations that involve risks, uncertainties and assumptions
MD&A now says: "This discussion and analysis are intended to provide an understanding of our results of operations, financial condition and cash flows and contain forward-looking statements reflecting current expectations that involve risks, uncertainties and assumptions
FormDelta — Insider Trading Alerts
What AtriCure, Inc. changed in their own words, quarter over quarter.
www.formdelta.com
November 5, 2026 at 9:28 PM
📄 #ATRC 10-Q — what changed
MD&A now says: "This discussion and analysis are intended to provide an understanding of our results of operations, financial condition and cash flows and contain forward-looking statements reflecting current expectations that involve risks, uncertainties and assumptions
MD&A now says: "This discussion and analysis are intended to provide an understanding of our results of operations, financial condition and cash flows and contain forward-looking statements reflecting current expectations that involve risks, uncertainties and assumptions
AtriCure $ATRC reported Q3 2026 Adj EPS of $0.17, beating the $0.01 estimate by 1600.0%. Revenue of $154.4M beat the $151.2M estimate by 2.1%.
https://fundspec.ai/s/ATRC/earnings
Daily bullish and bearish AI signals on every US stock.
https://fundspec.ai/s/ATRC/earnings
Daily bullish and bearish AI signals on every US stock.
November 3, 2026 at 9:14 PM
AtriCure $ATRC reported Q3 2026 Adj EPS of $0.17, beating the $0.01 estimate by 1600.0%. Revenue of $154.4M beat the $151.2M estimate by 2.1%.
https://fundspec.ai/s/ATRC/earnings
Daily bullish and bearish AI signals on every US stock.
https://fundspec.ai/s/ATRC/earnings
Daily bullish and bearish AI signals on every US stock.
EURONAVAL 2026: Naval Group dan Technology Innovation Institute (TII) Tanda Tangani Perjanjian untuk Padukan Keahlian Mereka dalam Teknologi Bawah Air Otonom Canggih - https://www.antaranews.com/berita/5835855/euronaval-2026-naval-group-dan-technology-innovation-institute-tii-...
EURONAVAL 2026: Naval Group dan Technology Innovation Institute (TII) Tanda Tangani Perjanjian untuk Padukan Keahlian Mereka dalam Teknologi Bawah Air Otonom Canggih
- Technology Innovation Institute, yang merupakan pilar penelitian terapan dari Advanced Technology Research Council (ATRC) Abu Dhabi, telah menandatangani ...
www.antaranews.com
November 6, 2026 at 3:48 AM
EURONAVAL 2026: Naval Group dan Technology Innovation Institute (TII) Tanda Tangani Perjanjian untuk Padukan Keahlian Mereka dalam Teknologi Bawah Air Otonom Canggih - https://www.antaranews.com/berita/5835855/euronaval-2026-naval-group-dan-technology-innovation-institute-tii-...
#ATRC AtriCure Reports Third Quarter 2026 Financial Results
https://www.stocktitan.net/news/ATRC/atri-cure-reports-third-quarter-2026-financial-ycy489c8mg6v.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ATRC/atri-cure-reports-third-quarter-2026-financial-ycy489c8mg6v.html?utm_source=stocktitan-bluesky&utm_medium=social
AtriCure Reports Third Quarter 2026 Financial Results
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
November 3, 2026 at 9:01 PM
#ATRC AtriCure Reports Third Quarter 2026 Financial Results
https://www.stocktitan.net/news/ATRC/atri-cure-reports-third-quarter-2026-financial-ycy489c8mg6v.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/ATRC/atri-cure-reports-third-quarter-2026-financial-ycy489c8mg6v.html?utm_source=stocktitan-bluesky&utm_medium=social
🚨 $ATRC
On November 3, 2026 , AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2026. The Company will hold a conference call on November 3, 2026 at 4:30 p.m. Eastern Time to discuss the financial results.
On November 3, 2026 , AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2026. The Company will hold a conference call on November 3, 2026 at 4:30 p.m. Eastern Time to discuss the financial results.
SEC Filing: ATRC
Click to view the official SEC document.
www.sec.gov
November 3, 2026 at 9:01 PM
🚨 $ATRC
On November 3, 2026 , AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2026. The Company will hold a conference call on November 3, 2026 at 4:30 p.m. Eastern Time to discuss the financial results.
On November 3, 2026 , AtriCure, Inc. issued a press release regarding its financial results for the third quarter ended September 30, 2026. The Company will hold a conference call on November 3, 2026 at 4:30 p.m. Eastern Time to discuss the financial results.
📈 Nov 3, 2026: data in, watchlist out
📌 MONITOR tier (watch only): #RDVT #PRCH #LTC #IDT #ATRC
Charts & scores → https://jumpstartsignal.com/reports/2026/11/03/
Daily ✅ OPPORTUNITY & 🏆 SPOTLIGHT picks, free → https://jumpstartsignal.com
#stocks #watchlist #momentum
📌 MONITOR tier (watch only): #RDVT #PRCH #LTC #IDT #ATRC
Charts & scores → https://jumpstartsignal.com/reports/2026/11/03/
Daily ✅ OPPORTUNITY & 🏆 SPOTLIGHT picks, free → https://jumpstartsignal.com
#stocks #watchlist #momentum
Jumpstart Signal - November 3, 2026
SRI-filtered stock screening report for November 3, 2026. Daily signals with technical analysis and sentiment.
jumpstartsignal.com
November 4, 2026 at 12:50 PM
📈 Nov 3, 2026: data in, watchlist out
📌 MONITOR tier (watch only): #RDVT #PRCH #LTC #IDT #ATRC
Charts & scores → https://jumpstartsignal.com/reports/2026/11/03/
Daily ✅ OPPORTUNITY & 🏆 SPOTLIGHT picks, free → https://jumpstartsignal.com
#stocks #watchlist #momentum
📌 MONITOR tier (watch only): #RDVT #PRCH #LTC #IDT #ATRC
Charts & scores → https://jumpstartsignal.com/reports/2026/11/03/
Daily ✅ OPPORTUNITY & 🏆 SPOTLIGHT picks, free → https://jumpstartsignal.com
#stocks #watchlist #momentum
Medicare Annual Open Enrollment is underway October 15–December 7, and the Alabama-Tombigbee Area Agency on Aging (ATRC Aging) is hosting special events across the Black Belt to help seniors review their Medicare coverage for 2027.
November 3, 2026 at 4:05 PM
Medicare Annual Open Enrollment is underway October 15–December 7, and the Alabama-Tombigbee Area Agency on Aging (ATRC Aging) is hosting special events across the Black Belt to help seniors review their Medicare coverage for 2027.
#$ATRC · AtriCure revenue rose to $154.5 million in the third quarter of 2026
AtriCure, Inc. reported third-quarter 2026 revenue of $154.5 million, up 15.0% year over year. The company's net income was $4.1 million.
#stocks #investing
AtriCure, Inc. reported third-quarter 2026 revenue of $154.5 million, up 15.0% year over year. The company's net income was $4.1 million.
#stocks #investing
AtriCure revenue rose to $154.5 million in the third quarter of 2026
AtriCure, Inc. reported third-quarter 2026 revenue of $154.5 million, up 15.0% year over year. The company's net income was $4.1 million.
insiderpost.org
November 4, 2026 at 9:26 AM
#$ATRC · AtriCure revenue rose to $154.5 million in the third quarter of 2026
AtriCure, Inc. reported third-quarter 2026 revenue of $154.5 million, up 15.0% year over year. The company's net income was $4.1 million.
#stocks #investing
AtriCure, Inc. reported third-quarter 2026 revenue of $154.5 million, up 15.0% year over year. The company's net income was $4.1 million.
#stocks #investing
AtriCure ($ATRC) – 13G holder update
• Holder: Vanguard Portfolio Management
• Stake: now 7.22% (about $225M)
• Filed: Oct 30 · Schedule 13G/A
📊 Track ownership filings at www.elixstocks.com
Educational purposes only. Not investment advice.
#Investing #Stocks #13G #ElixStocks
• Holder: Vanguard Portfolio Management
• Stake: now 7.22% (about $225M)
• Filed: Oct 30 · Schedule 13G/A
📊 Track ownership filings at www.elixstocks.com
Educational purposes only. Not investment advice.
#Investing #Stocks #13G #ElixStocks
Vanguard Portfolio Management LLC: 7.22% of AtriCure ($ATRC)
Schedule 13G/A filed Oct 30. Who filed, the stake, and how it changed.
elixstocks.com
October 31, 2026 at 2:26 PM
AtriCure ($ATRC) – 13G holder update
• Holder: Vanguard Portfolio Management
• Stake: now 7.22% (about $225M)
• Filed: Oct 30 · Schedule 13G/A
📊 Track ownership filings at www.elixstocks.com
Educational purposes only. Not investment advice.
#Investing #Stocks #13G #ElixStocks
• Holder: Vanguard Portfolio Management
• Stake: now 7.22% (about $225M)
• Filed: Oct 30 · Schedule 13G/A
📊 Track ownership filings at www.elixstocks.com
Educational purposes only. Not investment advice.
#Investing #Stocks #13G #ElixStocks